Essential thrombocythemia

LE WE PMID CA

Essential thrombocythemia

849

Essentielle Thrombozythaemie

Essential thrombocythemia

Hypereosinophilic syndrome

JAK2V617F

Leukemia (chronic myeloic)

Leukemia (chronic neutrophilic)

Mastocytosis

MPLW515L

Myelofibrosis

Myeloproliferative syndromes

Polycythemia vera

Receptor (Erythropoietin)

Receptor (G CSF)

Receptor (Thrombopoietin)

Thrombosis (Prophylaxis)

2008 1	Essential thrombocythemia, polycythemia vera, and myelofibrosis: current management and the prospect of targeted therapy. [18429051] Am J Hematol 83(6): 491-7 (2008)
2004 2	Diagnosis and treatment of essential thrombocythemia. [15339671] Haematologica 89(8): 904 (2004)
2004 3	Practice guidelines for the therapy of essential thrombocythemia. A statement from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. [15003898] Haematologica 89(2): 215-32 (2004)
2009 4	Pathogenesis and management of essential thrombocythemia. [20008247] Hematology Am Soc Hematol Educ Program -(-): 621-8 (2009)
2008 5	New advances in the pathogenesis and therapy of essential thrombocythemia. [19074062] Hematology Am Soc Hematol Educ Program -(-): 76-82 (2008)
2007 6	Essential thrombocythemia. [17210076] Orphanet J Rare Dis 2(-): 3 (2007)
2011 7	How I treat essential thrombocythemia. [21106990] Blood 117(5): 1472-82 (2011)
2009 8	Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference. [19278953] Blood 113(20): 4829-33 (2009)
2004 9	Towards a rational treatment of essential thrombocythemia, despite limited evidence and old prejudices. [15003887] Haematologica 89(2): 137-8 (2004)
2008 10	Childhood polycythemia vera and essential thrombocythemia: does their pathogenesis overlap with that of adult patients? [18245648] Haematologica 93(2): 169-72 (2008)
2008 11	Prevention of thrombosis in polycythemia vera and essential thrombocythemia. [18310537] Haematologica 93(3): 331-5 (2008)
2006 12	Classification, diagnosis and management of myeloproliferative disorders in the JAK2V617F era. [17124067] Hematology Am Soc Hematol Educ Program -(-): 240-5 (2006)
2006 13	Role of JAK-STAT signaling in the pathogenesis of myeloproliferative disorders. [17124066] Hematology Am Soc Hematol Educ Program -(-): 233-9, 510 (2006)
2010 14	Rethinking disease definitions and therapeutic strategies in essential thrombocythemia and polycythemia vera. [21239782] Hematology Am Soc Hematol Educ Program 2010(-): 129-34 (2010)
2007 15	Navigating the evolving paradigms in the diagnosis and treatment of myeloproliferative disorders. [18024651] Hematology Am Soc Hematol Educ Program -(-): 355-62 (2007)
2008 16	The JAK2V617F mutation in polycythemia vera and other myeloproliferative disorders: one mutation for three diseases? [19074061] Hematology Am Soc Hematol Educ Program -(-): 69-75 (2008)
2008 17	Myeloproliferative syndromes: diagnosis and therapeutic options. [19202955] Pol Arch Med Wewn 118(12): 756-60 (2008)
2007 18	The chronic myeloproliferative disorders and mutation of JAK2: Dameshek's 54 year old speculation comes of age. [17336249] Best Pract Res Clin Haematol 20(1): 5-12 (2007)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Essential thrombocythemia.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Essential thrombocythemia.php on line 92